Catherine Conlon: Time to adopt commonsense approach to obesity

Brazil's national food guidelines don’t dwell on nutrients, calories or weight loss. File picture: iStock
Almost half of adolescents with obesity given a ground-breaking new treatment managed to lose enough weight to drop below the clinical cut-off for obesity, according to new research presented at the European Congress on Obesity.
The treatment, Semaglutide, is sold under the brand name Wegovy in Ireland and is a medication used for long-term weight management. Almost three-quarters (74%) of 12-18 years olds in the study moved down at least one weight category. The average weight loss was 18kg.